136 related articles for article (PubMed ID: 35273891)
1. Vasoactive Intestinal Peptide-Secreting Pancreatic Neuroendocrine Tumor: A Case Report.
Thivacaren S; Suganthan N; Sujanitha V; Sutharshan V
Cureus; 2022 Mar; 14(3):e22819. PubMed ID: 35273891
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report.
Nilubol N; Freedman EM; Quezado MM; Patel D; Kebebew E
J Clin Endocrinol Metab; 2016 Oct; 101(10):3564-3567. PubMed ID: 27583474
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Vasoactive Intestinal Peptide-Producing Tumor as a Rare Cause of Acute Diarrhea and Severe Hypokalemia.
Giampatzis V; Kotsiari C; Bostantzis P; Chrisoulidou A; Fotiadou A; Loti S; Papantoniou S; Papadopoulou P
J Med Cases; 2023 Oct; 14(9-10):307-316. PubMed ID: 37868325
[TBL] [Abstract][Full Text] [Related]
4. A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resection.
Sakurai M; Wakabayashi T; Kondo Y; Ikeda E; Watanabe K; Takei A; Okazaki H; Okada K; Ebihara K; Kakiuchi N; Ogawa S; Fukushima N; Ishibashi S
Endocr J; 2023 Jun; 70(6):573-579. PubMed ID: 36889692
[TBL] [Abstract][Full Text] [Related]
5. Intractable and dramatic diarrhea in liver transplantation recipient with vasoactive intestinal peptide-producing tumor after split liver transplantation: a case report.
Haiqing W; Jiayin Y; Jian Y; Lunan Y
Transplant Proc; 2015; 47(1):171-3. PubMed ID: 25596962
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive Intestinal Peptide Tumor as the Cause of Persistent Diarrhea: A Diagnostic Challenge.
Lopes S; Alves M; Rodrigues P
Cureus; 2022 Sep; 14(9):e29130. PubMed ID: 36258959
[TBL] [Abstract][Full Text] [Related]
7. A case of the watery diarrhea-hypokalemia-achlorhydria syndrome: successful preoperative treatment of watery diarrhea with a somatostatin analogue.
Yoshioka M; Sakazume M; Fukagawa M; Seki T; Honma K; Uchida K; Yoshida K; Miyake Y; Yamaguchi K
Jpn J Clin Oncol; 1989 Sep; 19(3):294-8. PubMed ID: 2554028
[TBL] [Abstract][Full Text] [Related]
8. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
[TBL] [Abstract][Full Text] [Related]
9. [Use of a somatostatin analog to improve a patient's condition and the subsequent diagnosis of pancreatic VIPoma:a case report].
Kawahara S; Ueki T; Tsutsumi K; Oda T; Kobayashi S; Fujisawa T; Nawa T; Sadamori H; Ono K; Omonishi K
Nihon Shokakibyo Gakkai Zasshi; 2020; 117(1):84-91. PubMed ID: 31941861
[TBL] [Abstract][Full Text] [Related]
10. Octreotide reverses shock due to vasoactive intestinal peptide-secreting adrenal pheochromocytoma: A case report and review of literature.
Hu X; Cao W; Zhao M
World J Clin Cases; 2018 Nov; 6(14):862-868. PubMed ID: 30510956
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic VIPoma as a Differential Diagnosis in Chronic Pediatric Diarrhea: A Case Report and Review of the Literature.
Bonilla Gonzalez C; Rusinque J; Uribe C; Carias A; Contreras ML
J Med Cases; 2021 May; 12(5):195-201. PubMed ID: 34434457
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Irreversible Watery Diarrhea, Severe Metabolic Acidosis, Hypokalemia and Achloridria Syndrome Related to Vasoactive Intestinal Peptide Secreting Malignant Pheochromocytoma.
Negro A; Verzicco I; Tedeschi S; Campanini N; Zanelli M; Negri E; Farnetti E; Nicoli D; Palladini B; Santi R; Cunzi D; Calvi A; Coghi P; Gerra L; Volpi R; Graiani G; Cabassi A
Front Endocrinol (Lausanne); 2021; 12():652045. PubMed ID: 33815297
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic VIPomas from China: Case reports and literature review.
Chen C; Zheng Z; Li B; Zhou L; Pang J; Wu W; Zheng C; Zhao Y
Pancreatology; 2019 Jan; 19(1):44-49. PubMed ID: 30391116
[TBL] [Abstract][Full Text] [Related]
14. [VIPoma of the Pancreas].
Steck A; Nebiker C; Capraro J; Yurtsever H; Toutonji AA; Struja T
Praxis (Bern 1994); 2021 Sep; 110(11):637-642. PubMed ID: 34465193
[TBL] [Abstract][Full Text] [Related]
15. VIPoma with expression of both VIP and VPAC1 receptors in a patient with WDHA syndrome.
Nakayama S; Yokote T; Kobayashi K; Hirata Y; Hiraiwa T; Komoto I; Miyakoshi K; Yamakawa Y; Takubo T; Tsuji M; Imamura M; Hanafusa T
Endocrine; 2009 Apr; 35(2):143-6. PubMed ID: 19184565
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic vasoactive intestinal polypeptide-oma as a cause of secretory diarrhoea.
Masel SL; Brennan BA; Turner JH; Cullingford GL; Cullen DJ
J Gastroenterol Hepatol; 2000 Apr; 15(4):457-60. PubMed ID: 10824894
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of pancreatic vasoactive intestinal polypeptide-secreting tumor: a case report.
Yeh CN; Chen MF; Chen TC
Hepatogastroenterology; 2001; 48(38):421-3. PubMed ID: 11379322
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic vasoactive intestinal polypeptide-secreting tumor: report of a case.
Sheu HW; Chou SY; Yang KC; Kao CR; Yang TL; Shih CC
Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):931-5. PubMed ID: 2559939
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review.
Schizas D; Mastoraki A; Bagias G; Patras R; Moris D; Lazaridis II; Arkadopoulos N; Felekouras E
J BUON; 2019; 24(2):415-423. PubMed ID: 31127985
[TBL] [Abstract][Full Text] [Related]
20. Chronic Diarrhea Secondary to Newly Diagnosed VIPoma.
Farina DA; Krogh KM; Boike JR
Case Rep Gastroenterol; 2019; 13(1):225-229. PubMed ID: 31123451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
